Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents

In chronic human immunodeficiency virus (HIV)-1 infection, long-lived latently infected cells are the major barrier to virus eradication and functional cure. Several therapeutic strategies to perturb, eliminate, and/or control this reservoir are now being pursued in the clinic. These strategies incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Delagrèverie, Héloïse M., Delaugerre, Constance, Lewin, Sharon R., Deeks, Steven G., Li, Jonathan Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066458/
https://www.ncbi.nlm.nih.gov/pubmed/27757411
http://dx.doi.org/10.1093/ofid/ofw189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066458/
https://www.ncbi.nlm.nih.gov/pubmed/27757411
http://dx.doi.org/10.1093/ofid/ofw189

Ejemplares similares